Home Products Spectramune’s Third Clinical Immunity Study Announced by PLT Health Solutions

Spectramune’s Third Clinical Immunity Study Announced by PLT Health Solutions

by Newsroom


PLT Health’s Spectramune demonstrates impressive immune support with 23% fewer respiratory illness episodes and 30% less severe symptoms in clinical trials. This ashwagandha-haritaki blend boosts both innate and adaptive immunity without overstimulation.

The immune health supplement space is getting a major boost with PLT Health Solutions’ announcement of their latest clinical study on Spectramune™ Immune Defense Complex.[1] The study follows a successful pilot published in 2024,[2] providing added evidence that this unique botanical blend may help support a stronger, more balanced immune system.

Spectramune Study #3 Incoming: 30% Less…



Source link

You may also like

About Us

Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Health Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC